Thus, although IC50 values are predictive of immunogenicity (as measured by CD8+ T cell responses; refs. 19, 27, 28), they are not predictors of tumor rejection and there is a great need to improve prediction of TRMNs over neoantigens with only high affinity for MHC. The gene discussed is HLA-C; the disease is neoplasm.